![Peter N. Laivins](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Peter N. Laivins
Directeur/Membre du Conseil chez GENEXINE, INC.
Profil
Mr. Peter N.
Laivins is an Independent Director at Genexine, Inc. He is on the Board of Directors at Genexine, Inc. Mr. Laivins was previously employed as a Head-Development by Merrimack Pharmaceuticals, Inc. and a Vice President-Commercial & Strategic Marketing by Elan Biopharmaceuticals, Inc. He received his undergraduate degree from McGill University and an MBA from McGill University.
Postes actifs de Peter N. Laivins
Sociétés | Poste | Début |
---|---|---|
GENEXINE, INC. | Directeur/Membre du Conseil | - |
Anciens postes connus de Peter N. Laivins
Sociétés | Poste | Fin |
---|---|---|
MERRIMACK PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/04/2017 |
Elan Biopharmaceuticals, Inc.
![]() Elan Biopharmaceuticals, Inc. Medical DistributorsDistribution Services Elan Biopharmaceuticals, Inc. distributes drugs and pharmaceuticals. It currently distributes three concentrated morphine sulfate oral solutions which include RoxanolT CII, Roxanol-TT CII and Roxanol 100T CII. Elan Biopharmaceuticals is located in San Diego, CA. | Sales & Marketing | 01/01/2010 |
Formation de Peter N. Laivins
McGill University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
GENEXINE, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Merrimack Pharmaceuticals, Inc.
![]() Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Elan Biopharmaceuticals, Inc.
![]() Elan Biopharmaceuticals, Inc. Medical DistributorsDistribution Services Elan Biopharmaceuticals, Inc. distributes drugs and pharmaceuticals. It currently distributes three concentrated morphine sulfate oral solutions which include RoxanolT CII, Roxanol-TT CII and Roxanol 100T CII. Elan Biopharmaceuticals is located in San Diego, CA. | Distribution Services |